The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

Heart

Volumn 96, Issue 20, 2010, Pages 1617-1621

  Jernberg, Tomas ^a   Attebring, Mona F ^b   Hambraeus, Kristina ^c   Ivert, Torbjorn ^a   James, Stefan ^d   Jeppsson, Anders ^e   Lagerqvist, Bo ^d   Lindahl, Bertil ^d   Stenestrand, Ulf ^f   Wallentin, Lars ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c FALUN HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CAREGIVER; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DEATH; EVIDENCE BASED PRACTICE; HEALTH SERVICE; HEART DISEASE; HEART SURGERY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNET; MONITORING; ONLINE SYSTEM; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RECORDING; REVIEW; SECONDARY PREVENTION; SWEDEN; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; INTERNET; REGISTRIES; SWEDEN; TREATMENT OUTCOME;

EID: 78049273225     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.198804     Document Type: Review

References (29)

1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43. (Pubitemid 32675374)
2. Olsson C, Eriksson N, Stahle E, et al. The Swedish Heart Surgery Register: data quality for proximal thoracic aortic operations. Scand Cardiovasc J 2006;40:348-53. (Pubitemid 44803887)
3. Carlhed R, Bojestig M, Peterson A, et al. Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative. Circ Cardiovasc Qual Outcomes 2009;2:458-64.
4. Carlhed R, Bojestig M, Wallentin L, et al. Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. Am Heart J 2006;152:1175-81.
5. James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009;360:1933-45.
6. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-19.
7. Stenestrand U, Lindback J, Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation 2005;112:3225-31. (Pubitemid 43739366)
8. Stenestrand U, Lindback J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56.
9. Stenestrand U, Tabrizi F, Lindback J, et al. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation 2004;110:1896-902.
10. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-6.
11. Stenestrand U, Wallentin L. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet 2002;359:1805-11. (Pubitemid 34607055)
12. Szummer K, Lundman P, Jacobson SH, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 2009;120:851-8.
13. Alfredsson J, Stenestrand U, Wallentin L, et al. Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart 2007;93:1357-62.
14. Bjorck L, Rosengren A, Wallentin L, et al. Smoking in relation to ST-segment elevation acute myocardial infarction: findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions. Heart 2009;95:1006-11.
15. Bjorklund E, Stenestrand U, Lindback J, et al. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J 2006;27:1146-52.
16. Carlsson J, James SK, Lindback J, et al. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol 2009;53:1389-98.
17. Frobert O, Lagerqvist B, Carlsson J, et al. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol 2009;53:1660-7.
18. Held C, Tornvall P, Stenestrand U. Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery. Eur Heart J 2007;28:316-25.
19. Jeppsson A, Liden H, Johnsson P, et al. Surgical repair of post infarction ventricular septal defects: a national experience. Eur J Cardiothorac Surg 2005;27:216-21. (Pubitemid 40193129)
20. Norhammar A, Lindback J, Ryden L, et al. Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 2007;93:1577-83.
21. Norhammar A, Malmberg K, Ryden L, et al. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003;24:838-44.
22. Norhammar A, Stenestrand U, Lindback J, et al. Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 2008;94:1565-70.
23. Olsson C, Thelin S, Stahle E, et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 2006;114:2611-18.
24. Stenestrand U, Wallentin L. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort. Arch Intern Med 2003;163:965-71.
25. Tabrizi F, Englund A, Rosenqvist M, et al. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J 2007;28:2449-55.
26. Anon. European perspectives in cardiology. Circulation 2009;120:f91-3.
27. Anon. SWEDEHEART: Sweden's new online cardiac registry, the first of its kind. Eur Heart J 2009;30:2165-6.
28. James S, Wallentin L, Lagerqvist B. Swedish Coronary Angiography and Angioplasty Registry (SCAAR) study group. SCAAR-Scare in perspective. EuroIntervention 2009;5:1-4.
29. Lagerqvist B, Carlsson J, Frobert O, et al. Stent thrombosis in Sweden: a report from the Swedish CoronaryAngioplasty Registry Study Group. Circ Cardiovasc Interv 2009;2:401-8.